These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28728495)

  • 1. An evaluation of chemotherapy drug preparation process in hospitals in Turkey - A pilot study.
    Bayraktar-Ekincioglu A; Korubük G; Demirkan K
    J Oncol Pharm Pract; 2018 Dec; 24(8):563-573. PubMed ID: 28728495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical considerations in the preparation and dispensing of chemotherapy.
    Peters BG
    Top Hosp Pharm Manage; 1995 Jan; 14(4):78-88. PubMed ID: 10140430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Handling antineoplastic-drug admixtures at cancer centers: practices and pharmacist attitudes.
    Gregoire RE; Segal R; Hale KM
    Am J Hosp Pharm; 1987 May; 44(5):1090-5. PubMed ID: 3605119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-assurance testing of staff pharmacists handling cytotoxic agents.
    Harrison BR; Godefroid RJ; Kavanaugh EA
    Am J Health Syst Pharm; 1996 Feb; 53(4):402-7. PubMed ID: 8673660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actual conditions of the mixing of antineoplastic drugs for injection in hospitals in Osaka Prefecture, Japan.
    Yoshida J; Kosaka H; Nishida S; Kumagai S
    J Occup Health; 2008; 50(1):86-91. PubMed ID: 18285651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.
    Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Workers' Knowledge, Perceptions, and Behaviors Regarding Antineoplastic Drugs: Survey From British Columbia, Canada.
    Hon CY; Teschke K; Shen H
    J Occup Environ Hyg; 2015; 12(10):669-77. PubMed ID: 25897641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISOPP standards of practice. Safe handling of cytotoxics.
    International Society of Oncology Pharmacy Practicioners Standards Committee
    J Oncol Pharm Pract; 2007; 13 Suppl():1-81. PubMed ID: 17933809
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safe Handling of Cancer Chemotherapy Drugs in Pharmacy(Preparations, Transport and Safe Deposit)].
    Nomura H
    Gan To Kagaku Ryoho; 2017 Jul; 44(7):554-557. PubMed ID: 28790255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.
    Alexander M; King J; Lingaratnam S; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    J Oncol Pharm Pract; 2016 Apr; 22(2):219-27. PubMed ID: 25398311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines.
    Polovich M; Martin S
    Oncol Nurs Forum; 2011 Nov; 38(6):718-26. PubMed ID: 22037334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aseptic simulation test for cytotoxic drug production in isolators.
    Savry A; Correard F; Bennis Y; Roubaud S; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Mar; 71(6):476-81. PubMed ID: 24589539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a flowchart for risk assessment and allocation of preparation of monoclonal antibodies.
    Bauters T; Vandenbroucke J
    J Oncol Pharm Pract; 2019 Jan; 25(1):187-191. PubMed ID: 29199505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017.
    Schneider PJ; Pedersen CA; Scheckelhoff DJ
    Am J Health Syst Pharm; 2018 Aug; 75(16):1203-1226. PubMed ID: 29903709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A report on the National Commission on Cytotoxic Exposure.
    Gallelli JF
    J Pharm Technol; 1992; 8(2):55-64. PubMed ID: 10118896
    [No Abstract]   [Full Text] [Related]  

  • 18. Telepharmacy and bar-code technology in an i.v. chemotherapy admixture area.
    O'Neal BC; Worden JC; Couldry RJ
    Am J Health Syst Pharm; 2009 Jul; 66(13):1211-7. PubMed ID: 19535660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.
    Tortorici MP
    Hosp Pharm; 1980 Jun; 15(6):293, 295-6, 298-9 passim. PubMed ID: 10247268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turkish nurses' information about, and administration of, chemotherapeutic drugs.
    Kosgeroglu N; Ayranci U; Ozerdogan N; Demirustu C
    J Clin Nurs; 2006 Sep; 15(9):1179-87. PubMed ID: 16911059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.